Fluorescence sensing system by Soret-band LED light excitation for estimating relative talaporfin sodium concentration in skin

M. Takahashi, Tsunenori Arai

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The purpose of this study is to establish a sensing system to estimate relative talaporfin sodium concentration in skin to evaluate the risk of skin photosensitivity after photodynamic therapy (PDT) using percutaneous fluorescence spectroscopy. A prototype fluorescence sensing probe was made using a pair of 5-cm-long diffuse tips of plastic optical fibers for excitation light irradiation and fluorescence collection. Talaporfin sodium (2.5mg/kg) was intravenously administrated to three pigs, and the talaporfin sodium concentration in plasma was measured. The fluorescence sensing probe was attached to the skin and excited by a LED light with a peak wavelength of 409±16nm to obtain the mean area of the talaporfin sodium fluorescence spectral peak (Sfluo). The time history of the talaporfin sodium concentration in tissue was estimated using a two-compartment pharmacokinetic model. The time history of Sfluo was described as a composite function of the time history of the measured talaporfin sodium concentration in plasma and that of the estimated concentration in tissue as a double exponential decay function. The relative talaporfin sodium concentration in tissue and the relative contributions of fluorescence from tissue and plasma to Sfluo were estimated by the fluorescence system with the numerical pharmacokinetic model. Results also show that tissue compression equivalent to venous pressure might be effective to suppress the contribution of talaporfin sodium fluorescence in plasma.

Original languageEnglish
Pages (from-to)586-594
Number of pages9
JournalPhotodiagnosis and Photodynamic Therapy
Volume11
Issue number4
DOIs
Publication statusPublished - 2014 Dec 1

Fingerprint

Fluorescence
Light
Skin
Pharmacokinetics
Optical Fibers
Venous Pressure
Talaporfin
Fluorescence Spectrometry
Photochemotherapy
Plastics
Swine

Keywords

  • Fluorescence
  • Medical diagnosis
  • Photodynamic therapy
  • Skin photosensitivity
  • Talaporfin sodium

ASJC Scopus subject areas

  • Biophysics
  • Oncology
  • Dermatology
  • Pharmacology (medical)

Cite this

Fluorescence sensing system by Soret-band LED light excitation for estimating relative talaporfin sodium concentration in skin. / Takahashi, M.; Arai, Tsunenori.

In: Photodiagnosis and Photodynamic Therapy, Vol. 11, No. 4, 01.12.2014, p. 586-594.

Research output: Contribution to journalArticle

@article{cd0ccbeff15241b0b77a70a66c096e9b,
title = "Fluorescence sensing system by Soret-band LED light excitation for estimating relative talaporfin sodium concentration in skin",
abstract = "The purpose of this study is to establish a sensing system to estimate relative talaporfin sodium concentration in skin to evaluate the risk of skin photosensitivity after photodynamic therapy (PDT) using percutaneous fluorescence spectroscopy. A prototype fluorescence sensing probe was made using a pair of 5-cm-long diffuse tips of plastic optical fibers for excitation light irradiation and fluorescence collection. Talaporfin sodium (2.5mg/kg) was intravenously administrated to three pigs, and the talaporfin sodium concentration in plasma was measured. The fluorescence sensing probe was attached to the skin and excited by a LED light with a peak wavelength of 409±16nm to obtain the mean area of the talaporfin sodium fluorescence spectral peak (Sfluo). The time history of the talaporfin sodium concentration in tissue was estimated using a two-compartment pharmacokinetic model. The time history of Sfluo was described as a composite function of the time history of the measured talaporfin sodium concentration in plasma and that of the estimated concentration in tissue as a double exponential decay function. The relative talaporfin sodium concentration in tissue and the relative contributions of fluorescence from tissue and plasma to Sfluo were estimated by the fluorescence system with the numerical pharmacokinetic model. Results also show that tissue compression equivalent to venous pressure might be effective to suppress the contribution of talaporfin sodium fluorescence in plasma.",
keywords = "Fluorescence, Medical diagnosis, Photodynamic therapy, Skin photosensitivity, Talaporfin sodium",
author = "M. Takahashi and Tsunenori Arai",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.pdpdt.2014.09.001",
language = "English",
volume = "11",
pages = "586--594",
journal = "Photodiagnosis and Photodynamic Therapy",
issn = "1572-1000",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Fluorescence sensing system by Soret-band LED light excitation for estimating relative talaporfin sodium concentration in skin

AU - Takahashi, M.

AU - Arai, Tsunenori

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The purpose of this study is to establish a sensing system to estimate relative talaporfin sodium concentration in skin to evaluate the risk of skin photosensitivity after photodynamic therapy (PDT) using percutaneous fluorescence spectroscopy. A prototype fluorescence sensing probe was made using a pair of 5-cm-long diffuse tips of plastic optical fibers for excitation light irradiation and fluorescence collection. Talaporfin sodium (2.5mg/kg) was intravenously administrated to three pigs, and the talaporfin sodium concentration in plasma was measured. The fluorescence sensing probe was attached to the skin and excited by a LED light with a peak wavelength of 409±16nm to obtain the mean area of the talaporfin sodium fluorescence spectral peak (Sfluo). The time history of the talaporfin sodium concentration in tissue was estimated using a two-compartment pharmacokinetic model. The time history of Sfluo was described as a composite function of the time history of the measured talaporfin sodium concentration in plasma and that of the estimated concentration in tissue as a double exponential decay function. The relative talaporfin sodium concentration in tissue and the relative contributions of fluorescence from tissue and plasma to Sfluo were estimated by the fluorescence system with the numerical pharmacokinetic model. Results also show that tissue compression equivalent to venous pressure might be effective to suppress the contribution of talaporfin sodium fluorescence in plasma.

AB - The purpose of this study is to establish a sensing system to estimate relative talaporfin sodium concentration in skin to evaluate the risk of skin photosensitivity after photodynamic therapy (PDT) using percutaneous fluorescence spectroscopy. A prototype fluorescence sensing probe was made using a pair of 5-cm-long diffuse tips of plastic optical fibers for excitation light irradiation and fluorescence collection. Talaporfin sodium (2.5mg/kg) was intravenously administrated to three pigs, and the talaporfin sodium concentration in plasma was measured. The fluorescence sensing probe was attached to the skin and excited by a LED light with a peak wavelength of 409±16nm to obtain the mean area of the talaporfin sodium fluorescence spectral peak (Sfluo). The time history of the talaporfin sodium concentration in tissue was estimated using a two-compartment pharmacokinetic model. The time history of Sfluo was described as a composite function of the time history of the measured talaporfin sodium concentration in plasma and that of the estimated concentration in tissue as a double exponential decay function. The relative talaporfin sodium concentration in tissue and the relative contributions of fluorescence from tissue and plasma to Sfluo were estimated by the fluorescence system with the numerical pharmacokinetic model. Results also show that tissue compression equivalent to venous pressure might be effective to suppress the contribution of talaporfin sodium fluorescence in plasma.

KW - Fluorescence

KW - Medical diagnosis

KW - Photodynamic therapy

KW - Skin photosensitivity

KW - Talaporfin sodium

UR - http://www.scopus.com/inward/record.url?scp=84918781276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918781276&partnerID=8YFLogxK

U2 - 10.1016/j.pdpdt.2014.09.001

DO - 10.1016/j.pdpdt.2014.09.001

M3 - Article

VL - 11

SP - 586

EP - 594

JO - Photodiagnosis and Photodynamic Therapy

JF - Photodiagnosis and Photodynamic Therapy

SN - 1572-1000

IS - 4

ER -